A detailed history of Eversept Partners, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Eversept Partners, LP holds 4,105,313 shares of SNDX stock, worth $68.3 Million. This represents 6.25% of its overall portfolio holdings.

Number of Shares
4,105,313
Previous 3,613,631 13.61%
Holding current value
$68.3 Million
Previous $74.2 Million 6.52%
% of portfolio
6.25%
Previous 5.6%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.93 - $24.81 $8.82 Million - $12.2 Million
491,682 Added 13.61%
4,105,313 $79 Million
Q2 2024

Aug 14, 2024

BUY
$18.82 - $23.79 $9.04 Million - $11.4 Million
480,518 Added 15.34%
3,613,631 $74.2 Million
Q1 2024

May 15, 2024

SELL
$19.71 - $24.57 $4.93 Million - $6.15 Million
-250,131 Reduced 7.39%
3,133,113 $74.6 Million
Q4 2023

Feb 14, 2024

BUY
$11.39 - $21.67 $8.96 Million - $17.1 Million
786,999 Added 30.31%
3,383,244 $73.1 Million
Q3 2023

Nov 14, 2023

BUY
$14.52 - $21.77 $5.9 Million - $8.85 Million
406,513 Added 18.56%
2,596,245 $37.7 Million
Q2 2023

Nov 08, 2023

SELL
$19.35 - $22.31 $373,938 - $431,140
-19,325 Reduced 0.87%
2,189,732 $45.8 Million
Q2 2023

Aug 14, 2023

SELL
$19.35 - $22.31 $373,938 - $431,140
-19,325 Reduced 0.87%
2,189,732 $45.8 Million
Q1 2023

Nov 08, 2023

BUY
$20.66 - $28.98 $12.2 Million - $17.1 Million
588,344 Added 36.3%
2,209,057 $46.7 Million
Q1 2023

May 15, 2023

BUY
$20.66 - $28.98 $12.2 Million - $17.1 Million
588,344 Added 36.3%
2,209,057 $46.7 Million
Q4 2022

Nov 08, 2023

BUY
$20.64 - $26.24 $8.45 Million - $10.7 Million
409,279 Added 33.78%
1,620,713 $41.2 Million
Q4 2022

Feb 14, 2023

BUY
$20.64 - $26.24 $8.45 Million - $10.7 Million
409,279 Added 33.78%
1,620,713 $41.2 Million
Q3 2022

Nov 08, 2023

BUY
$18.51 - $24.79 $4.02 Million - $5.38 Million
217,072 Added 21.83%
1,211,434 $29.1 Million
Q3 2022

Nov 14, 2022

BUY
$18.51 - $24.79 $4.02 Million - $5.38 Million
217,072 Added 21.83%
1,211,434 $29.1 Million
Q2 2022

Nov 08, 2023

SELL
$13.64 - $19.48 $16.3 Million - $23.3 Million
-1,195,370 Reduced 54.59%
994,362 $19.1 Million
Q2 2022

Aug 15, 2022

BUY
$13.64 - $19.48 $13.6 Million - $19.4 Million
994,362 New
994,362 $19.1 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $941M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.